Prevalence and Clinical Effect of IDH1 and IDH2 Mutations Among Cytogenetically Normal Acute Myeloid Leukemia Patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prevalence and Clinical Effect of IDH1 and IDH2 Mutations Among Cytogenetically Normal Acute Myeloid Leukemia Patients

Published:2015-09 Issue:9 Volume:15 Page:550-555
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Aref Salah,Kamel Areida El Sayed,Abdel Aaal Mohamed Fathy,Adam Ola Mohamed,El-Ghonemy Mohamed Sabry,El-Baiomy Mohamed Ali,Zeid Tarek Abou

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference15 articles.

1. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461);Byrd;Blood,2002

2. Age and acute myeloid leukemia;Appelbaum;Blood,2006

3. New prognostic markers in acute myeloid leukemia: perspective from the clinic;Foran;Hematology,2010

4. Adverse impact of IDH1 and IDH2 mutations in primary AML: experience of the Spanish CETLAM group;Nomdedéu;Leuk Res,2012

5. IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication;Paschka;J Clin Oncol,2010

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, AML activity and molecular modeling of novel IDH2 inhibitors;Bioorganic Chemistry;2023-01

2. Genomic Landscape and Risk Stratification of Acute Myeloid Leukemia;Pathogenesis and Treatment of Leukemia;2023

3. Impact of mutations in epigenetic modifiers in acute myeloid leukemia: A systematic review and meta-analysis;Frontiers in Oncology;2022-11-28

4. Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation;Journal of Hematology & Oncology;2022-09-05

5. IDH2: A novel biomarker for environmental exposure in blood circulatory system disorders (Review);Oncology Letters;2022-06-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3